Hepatocellular carcinoma (HCC) is the most common type of liver cancer. It is a major global health concern with rising rates, particularly in North Africa and East Asia. Although potentially curable in the early stages, ...
Dec 29, 2023
0
4
]A recent study by the Centers for Disease Control and Prevention (CDC) finds that when mothers receive the flu vaccine, their babies experience fewer hospitalizations and emergency room visits for the flu, particularly if ...
Dec 28, 2023
0
16
Because it was not possible to remove a hard-to-reach bulge in the central lymphatic system, a team of doctors from the Department of Plastic Surgery and Hand Surgery at the University Hospital Zurich (USZ) created a new ...
Dec 20, 2023
0
18
Exercise intolerance, or the inability to perform physical activity at the expected or desired level, is one of the many symptoms associated with long COVID. In a study, Yale researchers help explain what is explicitly driving ...
Dec 19, 2023
0
32
The first postpartum depression pill approved for use in the United States is now available to women who need it, the drug's makers announced Thursday.
Dec 15, 2023
0
1
A new treatment strategy for locally advanced liver cancer, known as "reduce and remove," was announced by the Department of Surgery and Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, ...
Dec 14, 2023
0
35
Clinical trials are vital for advancing treatment options to the clinic but often face challenges in patient enrollment. For example, the Cancer Research Institute estimates that only 3% to 6% of eligible cancer patients ...
Dec 14, 2023
0
0
An experimental vaccine against human papillomavirus—HPV—appears to be safe, and most importantly, benefits patients who develop a rare airway cancer that manifests as recurrent obstructive growths requiring dozens, sometimes, ...
Systemic lupus erythematosus (SLE) is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...
Dec 8, 2023
0
5
Almost all postmenopausal patients aged 50-–69 years with stage I hormone receptor (HR)-positive breast cancer and low scores on a common genetic test who opted out of adjuvant radiotherapy were disease free five years ...
Dec 7, 2023
0
0
